Transition to injection amongst opioid users in Iran: Implications for harm reduction

International Journal of Drug Policy

Volumn 23, Issue 4, 2012, Pages 333-337

  Malekinejad, Mohsen ^a   Vazirian, Mohsen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Harm reduction; HIV; Iran; Opioid

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CULTURAL FACTOR; EPIDEMIC; HARM REDUCTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; OPIATE ADDICTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; TREND STUDY; VIRUS TRANSMISSION;

HARM REDUCTION; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; IRAN; OPIOID-RELATED DISORDERS; PUBLIC POLICY; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 84863855521     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.09.001     Document Type: Article

References (54)

1. Abelson J., Treloar C., Crawford J., Kippax S., van Beek I., Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction 2006, 101(4):548-555.
2. Bridge J. Route transition interventions: Potential public health gains from reducing or preventing injecting. International Journal of Drug Policy 2010, 21(2):125-128.
3. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduction Journal 2006, 3:10.
4. DCHQ. (2011a). News dated 22nd June 2011. In Farsi. Retrieved from http://www.dchq.ir/.
5. DCHQ. (2011b). News dated 8th March 2011. In Farsi. Retrieved from http://www.dchq.ir/.
6. De Kort G., Batra S., Pasaribu R., Vazirian M., Ul-Hassan S. Young people and drugs - Towards a comprehensive health promotion policy, final report 2005, Asian Harm Reduction Network (AHRN), Thailand.
7. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Heckathorn D.D., McKnight C., et al. The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City. Addiction 2007, 102(5):778-785.
8. Des Jarlais D.C., Casriel C., Friedman S.R., Rosenblum A. AIDS and the transition to illicit drug injection - Results of a randomized trial prevention program. British Journal of Addiction 1992, 87(3):493-498.
9. Edlin B.R. Prevention and treatment of hepatitis C in injection drug users. Hepatology 2002, 36(Suppl. 1):S210-S219.
10. Edlin B.R., Kresina T.F., Raymond D.B., Carden M.R., Gourevitch M.N., Rich J.D., et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases 2005, 40(Suppl. 5):S276-S285.
11. Fallahzadeh H., Morowatisharifabad M., Ehrampoosh M.H. HIV/AIDS epidemic features and trends in Iran, 1986-2006. AIDS and Behaviour 2009, 13(2):297-302.
12. Fuller C.M., Borrell L.N., Latkin C.A., Galea S., Ompad D.C., Strathdee S.A., et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. American Journal of Public Health 2005, 95(4):689-695.
13. Fuller C.M., Ompad D.C., Galea S., Wu Y., Koblin B., Vlahov D. Hepatitis C incidence - A comparison between injection and noninjection drug users in New York City. Journal of Urban Health 2004, 81(1):20-24.
14. Fuller C.M., Vlahov D., Ompad D.C., Shah N., Arria A., Strathdee S.A. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study. Drug and Alcohol Dependence 2002, 66(2):189-198.
15. Hosseini M., SeyedAlinaghi S., Kheirandish P., Esmaeli Javid G., Shirzad H., Karami N., et al. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Archives of Iranian Medicine 2010, 13(4):318-323.
16. INCB. (2010). The report of the International Narcotics Control Board (INCB) for 2009. Retrieved from http://www.incb.org/incb/en/annual-report-2009.html.
17. Irwin K.L., Edlin B.R., Faruque S., McCoy H.V., Word C., Serrano Y., et al. Crack cocaine smokers who turn to drug injection: Characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug and Alcohol Dependence 1996, 42(2):85-92.
18. Jafari S., Movaghar A.R., Craib K., Baharlou S., Mathias R. Socio-cultural factors associated with the initiation of opium use in Darab, Iran. International Journal of Mental Health and Addiction 2009, 7(2.).
19. Kelley M.S., Chitwood D.D. Effects of drug treatment for heroin sniffers: A protective factor against moving to injection?. Social Science and Medicine 2004, 58(10):2083-2092.
20. Lawrinson P., Ali R., Buavirat A., Chiamwongpaet S., Dvoryak S., Habrat B., et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008, 103(9):1484-1492.
21. Malekinejad, M., Mohraz, M., Razani, N., Khairandish, P., McFarland, W., Akbari, G., et al. (2008). Assessment of the use of respondent-driven sampling for studying populations most at risk of HIV infection [Doctoral Dissertation]. School of Public Health: University of California, Berkeley.
22. Malekinejad M., Razani N., Kheirandish P., McFarland W., Akbari G., et al. HIV and related risk behaviors of injecting drug users (IDU) in Iran: Findings from the first respondent-driven sampling (RDS) survey of IDU in Tehran in 2006-2007. Oral presentation, XVII International AIDS Conference, Mexico City, August 2008 2008.
23. MOHME Ministry of Health and Medical Education (MOHME) 2006, Islamic Republic of Iran.
24. MOHME Islamic republic of Iran country report on monitoring of the United Nations general assembly special session on HIV and AIDS, February 2010: National AIDS Committee Secretariat 2010, Ministry of Health and Medical Education, Tehran, Iran.
25. MOHME/CD.M. Statistics of HIV/AIDS in islamic republic of Iran: Quarterly, August 2010: Center for disease management 2010, Ministry of Health and Medical Education, Islamic Republic of Iran.
26. MOHME/SAPT.O. The annual report of substance abuse treatment and prevention office (SAPTO) 2010, Ministry of Health and Medical Education 2009, Tehran, I.R. of Iran.
27. Nasir S., Rosenthal D. The social context of initiation into injecting drugs in the slums of Makassar, Indonesia. International Journal of Drug Policy 2009, 20(3):237-243.
28. Nassirimanesh, B., Trace, M., & Roberts, M. (2005). The rise of harm reduction in the Islamic Republic of Iran. Retrieved from http://www.internationaldrugpolicy.net/publications.htm.
29. Neaigus A., Gyarmathy V.A., Miller M., Frajzyngier V.M., Friedman S.R., Des Jarlais D.C. Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes 2006, 41(4):493-503.
30. Neaigus A., Miller M., Friedman S.R., Hagen D.L., Sifaneck S.J., Ildefonso G., et al. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction 2001, 96(6):847-860.
31. Pirsaraee H.Y When parents use drugs: Key findings from qualitative research on parenting and children in Iran. Child and Family Social Work 2007, 12:113-122.
32. Rahimi-Movaghar A., Razaghi E.M., Sahimi-Izadian E., Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Diseases 2010, 14(1):e28-e33.
33. Razani N., Mohraz M., Kheirandish P., Malekinejad M., Malekafzali H., Mokri A., et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 2007, 102(9):1472-1482.
34. Razzaghi E.M., Movaghar A.R., Green T.C., Khoshnood K. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal 2006, 3:12.
35. Razzaghi E., Nassirimanesh B., Afshar P., Ohiri K., Claeson M., Power R. HIV/AIDS harm reduction in Iran. Lancet 2006, 368(9534):434-435.
36. Razzaghi E.M., Rahimi Movaghar A., Hosseini M., Madani S., Chatterjee A. Rapid situation assessment of drug abuse in Iran 1999, Iranian Welfare Organization and UNDCP, Tehran.
37. Roy E., Haley N., Leclerc P., Cedras L., Blais L., Boivin J.F. Drug injection among street youths in Montreal: Predictors of initiation. Journal of Urban Health 2003, 80(1):92-105.
38. Sanchez J., Chitwood D.D., Koo D.J. Risk factors associated with the transition from heroin sniffing to heroin injection: A street addict role perspective. Journal of Urban Health 2006, 83(5):896-910.
39. Sherman S.G., Latkin C.A. Drug users' involvement in the drug economy: Implications for harm reduction and HIV prevention programs. Journal of Urban Health 2002, 79(2):266-277.
40. Todd C.S., Safi N., Strathdee S.A. Drug use and harm reduction in Afghanistan. Harm Reduction Journal 2005, 2:13.
41. UNAIDS. (2008). Iran UNGASS report 2008. Retrieved from http://data.unaids.org/pub/Report/2008/iran_2008_country_progress_report_en.pdf.
42. UNODC. (2007). Afghanistan opium survey 2007. Executive summary. http://www.unodc.org/pdf/research/AFG07_ExSum_web.pdf.
43. UNODC. (2008). Epidemiology of drug use in Iran. Retrieved from http://www.unodc.org/iran/en/epidemiology.html.
44. van Ameijden E.J., van den Hoek J.A., Hartgers C., Coutinho R.A. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology 1994, 139(12):1153-1163.
45. Vazirian M., Kort G.D., Nassirimanesh B., Farhoudian A., Rad-Goudarzi R., Khazaeli A. Young people and drugs towards a comprehensive health promotion policy: Tehran report 2006, Asian Harm Reduction Network, United Nations Office on Drugs and Crime (UNODC) in I.R. of Iran, Ministry of Health and Medical Education - I.R. of Iran, Tehran, Iran.
46. Vazirian M., Nassirimanesh B., Zamani S., Ono-Kihara M., Kihara M., Ravari S.M., et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal 2005, 2:19.
47. Vickerman P., Hickman M., Rhodes T., Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. Journal of Acquired Immune Deficiency Syndromes 2006, 42(3):355-361.
48. Vlahov D., Fuller C.M., Ompad D.C., Galea S., Des Jarlais D.C. Updating the infection risk reduction hierarchy: Preventing transition into injection. Journal of Urban Health 2004, 81(1):14-19.
49. WHO/EMRO. (2007). RSA2 study by Drug Control Head Quarter (DCHQ) in 2007. Retrieved from http://www.emro.who.int/asd/Media/excel/Iran.xls.
50. Zamani S., Kihara M., Gouya M.M., Vazirian M., Ono-Kihara M., Razzaghi E.M., et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005, 19(7):709-716.
51. Zamani S., Kihara M., Gouya M.M., Vazirian M., Ono-Kihara M., Razzaghi E.M. HIV-1 prevalence and sexual characteristics of injecting drug users visiting treatment centers in Tehran, Iran: A potential bridge of HIV-1 infection from IDU to their sexual partners. Poster presentation, 7th International Congress on AIDS in Asia and Pacific 2005.
52. Zamani S., Kihara M., Gouya M.M., Vazirian M., Nassirimanesh B., Ono-Kihara M., et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndromes 2006, 42(3):342-346.
53. Zamani S., Ichikawa S., Nassirimanesh B., Vazirian M., Ichikawa K., Gouya M.M., et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy 2007, 18(5):359-363.
54. Zamani S., Vazirian M., Nassirimanesh B., Razzaghi E.M., Ono-Kihara M., Mortazavi Ravari S., et al. Needle and syringe sharing practices among injecting drug users in Tehran: A comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS and Behaviour 2008, 14(4):885-890.